KELSIE TESCHER: Open Payments
NPI 1184115685 · BISMARCK, ND. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$922 in 58 payments from 16 companies in 2025. Trend: 2023 $193 · 2024 $1,378 · 2025 $922
Food & beverage: $922
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $217 |
| Amgen Inc. | 11 | $155 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $86 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $68 |
| PFIZER INC. | 4 | $61 |
| Madrigal Pharmaceuticals | 2 | $61 |
| Novo Nordisk Inc | 3 | $55 |
| Lilly USA, LLC | 3 | $53 |
| Phathom Pharmaceuticals, Inc. | 2 | $33 |
| Alkermes, Inc. | 2 | $30 |
Products named: VRAYLAR, EVENITY, JARDIANCE, QULIPTA, CAPLYTA, NURTEC ODT, REZDIFFRA, MOUNJARO.
Industry payments across ND — which companies pay providers there.
